Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000007262 | SCV002225093 | uncertain significance | Heterotaxy, visceral, 4, autosomal | 2021-08-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACVR2B protein function. ClinVar contains an entry for this variant (Variation ID: 6859). This missense change has been observed in individual(s) with ACVR2B-related conditions (PMID: 9916847). This variant is present in population databases (rs121434438, ExAC 0.004%). This sequence change replaces valine with isoleucine at codon 494 of the ACVR2B protein (p.Val494Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. |
Breakthrough Genomics, |
RCV004691718 | SCV005189881 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000007262 | SCV000027458 | pathogenic | Heterotaxy, visceral, 4, autosomal | 1999-01-01 | no assertion criteria provided | literature only |